Evidence map›Paper›PMID 40953244›Full record

ArticleThe journal of extra-corporeal technology2025

Successful use of pulsatile flow and goal directed perfusion in a high-risk patient.

Mostafa Bagherinasab, Nathaniel H Darban

Abstract readCase Reports
In one paragraph

Article in The journal of extra-corporeal technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mostafa BagherinasabExtracorporeal life support, Baqiyatallah University of Medical Sciences, Sheikh Bahayi St. Mollasadra St. Vanak Square, Tehran, Iran.
Nathaniel H DarbanMidwestern University, 19555 N. 59th Avenue, Glendale, Arizona 85308, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of multi-organ failure resulting from cardiopulmonary bypass (CPB) is acknowledged as a significant contributor to increased morbidity and mortality rates during the postoperative period. This report discusses a patient who presents with multiple comorbidities, including renal failure, reduced ejection fraction, and a history of hypertension, and is being considered for coronary artery bypass grafting (CABG) along with aortic valve replacement surgery. The administration of CPB was customized to address the unique comorbid conditions of the patient, highlighting the critical objective of maintaining an oxygen delivery index (DO

Indexed as

Cardiopulmonary BypassCoronary Artery BypassPulsatile FlowAgedHeart Valve Prosthesis ImplantationHumansMaleCardiac indexOrgan perfusionOxygen delivery indexPulsatile flow

Identifiers

PMID40953244
PMCPMC12435815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.